COMPANIES COVERED
BioceptDownload FREE Report Sample
Download Free sampleLung Cancer Liquid Biops Market contains market size and forecasts of Lung Cancer Liquid Biops in Global, including the following market information:
Global Lung Cancer Liquid Biops Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Lung Cancer Liquid Biops market was valued at 438 million in 2021 and is projected to reach US$ 1056.2 million by 2028, at a CAGR of 13.4% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Exosomes and RNA Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Lung Cancer Liquid Biops include Biocept, EntroGen, Cynvenio Biosystems, Exosome Diagnostics, F. Hoffmann-La Roche, Clearbridge BioMedics, Bio-Rad Laboratories, Agena Bioscience and Cancer Genetics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Lung Cancer Liquid Biops companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Lung Cancer Liquid Biops Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Lung Cancer Liquid Biops Market Segment Percentages, by Type, 2021 (%)
Exosomes and RNA
CTCs and ctDNA
Global Lung Cancer Liquid Biops Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Lung Cancer Liquid Biops Market Segment Percentages, by Application, 2021 (%)
Hospitals and Clinics
Physicians'Office Laboratories
Clinical Diagnostic Laboratories
Global Lung Cancer Liquid Biops Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Lung Cancer Liquid Biops Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Lung Cancer Liquid Biops revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Lung Cancer Liquid Biops revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Biocept
EntroGen
Cynvenio Biosystems
Exosome Diagnostics
F. Hoffmann-La Roche
Clearbridge BioMedics
Bio-Rad Laboratories
Agena Bioscience
Cancer Genetics
CellMax Life
Nateras
MedGenome
OncoDNA
Genomic Health
Trovagene
Fluxion Biosciences
Biodesix
Epic Sciences
Shuwen Biotech
Personal Genome Diagnostics
Predicine
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
